Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance
A completed clinical trial evaluating molecular subtyping of extensive-stage small cell lung cancer and its clinical significance. The study…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma. [Phase 1, Phase 2]
A dose-escalation and expansion Phase 1/2 trial of ZG006 in neuroendocrine carcinoma and advanced small cell lung cancer is currently recrui…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC [Phase 3]
A Phase 3 trial examining Lurbinectedin alone or with Irinotecan versus Topotecan in relapsed small cell lung cancer is currently recruiting…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Cognitive Screening in Lung Cancer Patients
A clinical trial investigating cognitive screening in lung cancer patients is currently recruiting, including non-small cell and small cell …
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer [Phase 3]
Phase 3 clinical trial of Chiauranib Capsule for Small cell lung cancer has completed. The source does not provide results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) [Phase 1]
The CLAMP Phase 1 trial evaluating chemotherapy with allopurinol and MycoPhenolate in relapsed small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Molecular Analysis and Treatment Options of SCLC
A clinical trial at Shanghai Chest Hospital is investigating molecular analysis and treatment options for small-cell lung cancer and is curr…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating a combination of chemotherapy, immunotherapy, and radiotherapy for newly diagnosed stage IV small cell lung cance…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
A Travera Inc clinical trial (NCT04985357) evaluating mass response as a biomarker for tumor sensitivity to drugs has been withdrawn; no res…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin [Phase 2]
A Phase 2 trial evaluating first-line therapy for extensive-stage small cell lung cancer using a combination of trilaciclib, envafolimab, et…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers [Phase 1, Phase 2]
Clinical trial update for Galinpepimut-S in combination with pembrolizumab in selected advanced cancers (Phase 1/2) with completed status an…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs [Phase 2]
Phase 2 randomized trial evaluating topotecan with the ATR inhibitor M6620 (VX-970) in small cell lung cancer and extrapulmonary small cell …
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer [Phase 1, Phase 2]
Completed Phase I/II study of nivolumab, ipilimumab, and plinabulin in recurrent small cell lung cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease [Phase 2]
This Phase 2 trial update reports results for nivolumab plus ipilimumab in limited-stage small cell lung cancer (NCT02046733), with results …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
This document reports the completion of a clinical trial evaluating atezolizumab combined with chemotherapy for extensive-stage small cell l…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours [Phase 1]
This clinical trial update reports the completion of a first-in-human Phase 1 study evaluating AZD8701 with or without durvalumab in adults …
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer [Phase 3]
A Phase 3 global, open-label randomized trial evaluating RRx-001 with a platinum doublet in small cell lung cancer; the study is currently a…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer [NA]
A completed study evaluating a cognitive-behavioral model to reduce dyspnea in patients with lung cancer has been reported.
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases [NA]
This clinical trial update describes a study evaluating stereotactic radiation for patients with small cell lung cancer and 1–10 brain metas…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
Clinical trial update reporting safety, pharmacokinetics, and efficacy findings for tinostamustine in patients with advanced solid tumors, i…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating toripalimab and JS004 in combination with platinum-based chemotherapy for relapsed and extensive-stage small cell…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating antirotiinib hydrochloride in combination with whole brain radiotherapy for small cell lung cancer with br…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial comparing HS-20093 to Topotecan in relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC) [Phase 1]
Phase 1 clinical trial update showing results for Amgen’s AMG 757 and AMG 404 in Small Cell Lung Cancer; results were posted in October 2024…